MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517059478 A) filed by Segena Corporation S. A., Montevideo, Uruguay, on June 20, for 'enhancing oligonucleotide immunomodulatory activity through dianophore long-lasting modification: methods and applications.'

Inventor(s) include Bosi, Susanna; and Tisminetzky, Sergio Gabriel.

The application for the patent was published on July 4, under issue no. 27/2025.

According to the abstract released by the Intellectual Property India: "Dianophore Long-Lasting Modifications ooff oligonucleotides with immunomodulatory and homeostatic properties (including the proliferation of pluripotent mesenchymal stem cells (MSC) of animals, including humans). Different ...